Maryland shoppers get an Energy Star tax holiday this combined Valentine's/Presidents Day weekend
How taxes have -- and haven't -- changed since JFK became the first president to visit IRS headquarters

'Pharma bro' Martin Shkreli facing $4.6 million tax lien

There are very few times when folks are on the Internal Revenue Service's side, but this might just be one of them.

The IRS has slapped pharmaceutical bad boy Martin Shkreli with a tax lien totaling more than $4.6 million.

Martin-ShkreliFormer pharmaceutical executive Martin Shkreli in happier times.

Shkreli became a global villain last year when he jacked up the U.S. market price of Daraprim from $13.50 per pill to $750 per pill overnight, a 5,556 percent increase. The anti-parasitic drug is used in AIDS treatment and at was produced by Turing Pharmaceuticals, which Shkreli founded and served as chief executive.

The tax lien against Shkreli's property in midtown Manhattan property alleges that he owes $3,431.85 from tax year 2013 and another $4,625,496.70 covering 2014.

The lien was prepared on Dec. 18, 2015 and filed with the New York Office of the City Register on Jan. 11, according to, which broke the news last week.

More bad money news: The IRS action is the latest financial blow to the 32-year-old Shkreli,

Last week it was revealed that Shkreli's E-Trade account value had plunged in just the last month from $46 million to now only $4 million.

CNBC reports that the dramatic drop was due to the stock price plunge of KaloBios Pharmaceuticals, where he once served as CEO. That company's stock made up most of his brokerage account, but its value tanked after Shkreli was arrested for federal securities fraud on Dec. 17, 2015, and subsequently was booted from his executive position within the company.

The news of Shkreli's reduced wealth came out in during a hearing in that case in Brooklyn federal court. His brokerage account was used to secure his $5 million release bond and its reduced value could endanger his bail.

Angering House members: Shkreli also made headlines when he appeared before a Congressional hearing Feb. 4 on drug pricing but refused to answer any questions from members of the panel.

Instead, the so-called pharma bro repeatedly read from a written statement citing his Fifth Amendment right not to incriminate himself.

But what really infuriated the House Committee on Oversight and Government Reform members was that Shkreli smirked his silent way through the hearing.

He eventually was asked to leave. 

The IRS, however, will be very happy to have him come in and talk about the money it says he owes Uncle Sam.

You also might find these items of interest:


Feed You can follow this conversation by subscribing to the comment feed for this post.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)